Leveraging MYC as a therapeutic treatment option for TNBC

por Carey, Jason P.W., Keyomarsi, Khandan
Publicado 2018

PKC iota promotes ovarian tumor progression through deregulation of cyclin E

por Nanos-Webb, Angela, Bui, Tuyen, Karakas, Cansu, Zhang, Dong, Carey, Jason P.W., Mills, Gordon B., Hunt, Kelly K., Keyomarsi, Khandan
Publicado 2015

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer

por Alexander, Angela, Karakas, Cansu, Chen, Xian, Carey, Jason P.W ., Yi, Min, Bondy, Melissa, Thompson, Patricia, Cheung, Kwok Leung, Ellis, Ian O., Gong, Yun, Krishnamurthy, Savitri, Alvarez, Ricardo H., Ueno, Naoto T., Hunt, Kelly K., Keyomarsi, Khandan
Publicado 2017

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration

por Chen, Xian, Yang, Dong, Carey, Jason P. W., Karakas, Cansu, Albarracin, Constance, Sahin, Aysegul A., Arun, Banu K., Guray Durak, Merih, Li, Mi, Kohansal, Mehrnoosh, Bui, Tuyen N., Ha, Min-Jin, Hunt, Kelly K., Keyomarsi, Khandan
Publicado 2021